SHANIQUE MCKITTRICK: Open Payments
NPI 1528833985 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,217 in 253 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $3,101 · 2025 $4,217
Food & beverage: $4,108Education: $109
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 20 | $712 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $637 |
| ABBVIE INC. | 31 | $523 |
| E.R. Squibb & Sons, L.L.C. | 37 | $511 |
| Teva Pharmaceuticals USA, Inc. | 24 | $471 |
| Otsuka America Pharmaceutical, Inc. | 25 | $359 |
| Supernus Pharmaceuticals, Inc. | 43 | $302 |
| Janssen Pharmaceuticals, Inc | 16 | $277 |
| Lundbeck LLC | 8 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, COBENFY, REXULTI, Qelbree, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
